Fundraising FoxGlycoregimmune
San Diego, US · Founded 2018 · Delaware corporation
Find your way into Glycoregimmune
Sign up to see every warm intro you have to Glycoregimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Glycoregimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
WM
Walter Marc HertzExecutive
OG
Oppel GreefExecutive
VK
Vipin Kumar ChaturvediExecutive
Board
RW
Raymond WattBoard director
AA
Albert AgroBoard director
AV
Abraham Van WykBoard director
Reported raises · per SEC filings
Form D private placements$26.9M disclosed across 4 rounds · 2015–2023
▶$15.6MraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$15.6MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Walter Marc HertzExecutive Officer, Director
- Offering amount
- $15.6M
- Amount sold
- $15.6M
- Sales commissions
- $245K
- Placement agents
- Ecoban Securities Corporation
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.3MraisedDec 2022 · 1 investors · BiotechnologyRule 506(b)
▶$1.3MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ABRAHAM VAN WYCKDirector
- WALTER MARC HERTZExecutive Officer, Director
- VIPIN KUMAR CHATURVEDIExecutive Officer, Director
- ALBERT AGROExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.3M
- Sales commissions
- $25K
- Placement agents
- ECOBAN SECURITIES CORPORATION
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedNov 2018 · 4 investors · Other Health CareRule 506(b)
▶$5.7MraisedNov 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- W MARC HERTZExecutive Officer, Director
- GERALD YAKATANDirector
- SEAN G EDWARDSExecutive Officer
- ALBERT AGRODirector
- VIPIN KUMARDirector
- ABRAHAM VAN WYCKDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.4MraisedApr 2015 · 2 investors · Other Health CareRule 506(b)
▶$4.4MraisedApr 2015 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Raymond WattDirector
- Walter Marc HertzExecutive Officer, Director
- Albert AgroDirector
- Oppel GreefExecutive Officer
- Abraham Van WykDirector
- Vipin Kumar ChaturvediExecutive Officer, Director
- Offering amount
- $6.4M
- Amount sold
- $4.4M
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Glycoregimmune raised?
- Glycoregimmune has disclosed $26.9M raised across 4 rounds.
- Where is Glycoregimmune headquartered?
- Glycoregimmune is headquartered in San Diego, US.